netFormulary NHS
North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group
 Search
 Formulary Chapter 12: Ear, nose and oropharynx - Full Chapter
12.01.01  Expand sub section  Otitis externa
12.01.01  Expand sub section  Astringent preparations
Aluminium acetate 
(ear drops)
View adult BNF View childrens BNF  Track Changes 		Unlicensed Drug Unlicensed
Red

Available as 8% and 13% ear drops for treatment of inflammation in otitis externa.

For the 8% preparation, dilute 8 parts aluminium acetate ear drops (13%) with 5 parts purified water. Must be freshly prepared.

An alternative astringent is EarCalm® spray (Acetic acid 2%),

 

 

 

 
   
12.01.01  Expand sub section  Anti-inflammatory preparations
12.01.01  Expand sub section  Anti-infective preparations
12.01.01  Expand sub section  Other aural preparations to top
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
SMC
 Scottish Medicines Consortium
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG
Blueteq
 High Cost Drug Approval System

Traffic Light Status Information

Status Description

Red

 Medicines that can only be prescribed within Secondary Care. Examples of medicines which fall into this category are: Certain new medicines and new indications for older medicines where there is at present no experience of use in Primary Care. Medicines or dressings not available or prescribable in Primary Care. Where a medicine has been classified as Amber E, but an approved shared-care guideline is not yet available   

Amber

 Medicines which can be prescribed within Secondary Care, but are only suitable for prescribing in Primary Care after specialist referral. There is no need for approved shared care guidelines for medicines in this category. This replaces Amber 2 on the North Staffs Formulary.   

Amber E

 Medicines which can be prescribed within Secondary Care, but are only considered suitable for prescribing in Primary Care under an approved shared-care agreement (ESCA) or Rationale for Initiation, Continuation and Discontinuation (RICaD). This replaces Amber 1 on the North Staffs Formulary  

Green

 Medicines which can be prescribed in either Primary or Secondary Care.  

Grey

 These medicines have been reviewed by the New Medicines Committee and the Area Prescribing Committee and found not to be suitable for inclusion in the Joint Formulary. Inadequate or weak evidence for efficacy No clearly defined local need Lack of long term safety data No perceived benefit over established formulary alternatives Prescribers can consider these medicines where formulary alternatives are unsuitable, ineffective or not tolerated.  

netFormulary